Skip to content

Effects of an Acute and Chronic Training Protocol Associated to the Inter-set Velocity Loss

Neuromuscular, Physiological and Performance Changes After an Acute and Chronic Training Protocol Associated to the Inter-set Velocity Loss

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03964519
Enrollment
30
Registered
2019-05-28
Start date
2019-07-01
Completion date
2019-09-15
Last updated
2019-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

velocity loss, Tensiomiography, resistance training

Brief summary

This study evaluates different performance, physiological and neuromuscular changes after acute and chronic resistance training intervention in physically active men. The participants will train with a single exercise (full squat) and will be monitored with a linear encoder. The experiment will consist of between 3 to 6 sets between 70% to 85% of 1RM in the full squat exercise. Two main groups will form the intervention: one group will perform inter-set repetitions until there will be a 20% of velocity loss compared to the first repetition, while the second group will have a 40% of velocity loss.

Detailed description

The main dependent variables and instruments will be: 1. Tensyomiography: neuromuscular properties of the vastus lateral (VL), rectus femoris (RF) and vastus medialis (VM) from the dominant leg. 2. Force platform: kinetic variables in relation to a countermovement jump. 3. Near-infrared spectrography: oxygen saturation in the VL and VM. 4. Termographic camera: low limbs temperatura. 5. Linear encoder: mean propulsive velocity from each repetition 6. Electromyography: amplitude and frequency parameters related to a knee extension maximum voluntary contraction test. 7. Strain gauge: maximum isometric force.

Interventions

OTHERAcute changes

In a crossover design, participants will be randomized to perform on Day 1, 3 sets of repetitions (depending on each treatment group) at 70% or 1RM in the full squat exercise. 48-h later, same will be performed but in the contrary crossover arm.

OTHERChronic changes

In a randomized control trial, participants will train during 6 weeks the full squat exercise, 2 days in the week (minimum between-days rest of 48h). Intensity will vary from 70% to 85 of 1RM, and training volume from 3 to 6 sets.

Prior to any intervention, all participants will perform a familiarization of the exercise session, together with a progressive resistance test to estimate the 1 RM

Sponsors

Alejandro Muñoz López
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* To be healthy * Without injuries or actual illnesses * More than 2 years of experience in resistance training or federative sports

Exclusion criteria

* To be sick or injured * To have programmed during the intervention phase a dramatic change in the lifestyle

Design outcomes

Primary

MeasureTime frameDescription
Contraction time7 weeksTime between 10% to 90% on the displacement-time curve assessed with the Tensiomiograhpy
Maximum displacement7 weeksMaximum displacement point the displacement-time curve assessed with the Tensiomiograhpy

Secondary

MeasureTime frameDescription
Muscle temperature7 weeksLow limb muscles temperature assessed with a termographic camera
Mean propulsive velocity7 weeksIndividual repetitions mean propulsive velocity during the full squat exercise, assessed with a linear encoder
Kinetic variables in the jump7 weeksKinetic variables related to the force-time curve registered with the force platform during jumps
Peak isometric force7 weeksMaximum force achieved during a knee extension at 120º
Amplitude (RMS) and frequency outputs7 weeksMuscle electrical activity assessed with an EMG
Muscle tissue oxygen7 weeksOxygen in the muscle tissue assessed via near-infrared spectroscopy

Contacts

Primary ContactJesus Gustazo Ponce, PhD
jesusgustavo.ponce@uca.es+34 658 87 41 34
Backup ContactAlejandro Muñoz López, PhD
amunoz26@us.es0034 699661447

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026